Nurix Therapeutics Inc (NAS:NRIX)
$ 25.22 +0.090 (+0.36%) Market Cap: 2.62 Bil Enterprise Value: 2.23 Bil PE Ratio: 0 PB Ratio: 6.49 GF Score: 61/100

Nurix Therapeutics Inc to Host Investor Update Call Transcript

Jun 8, 2026 / 12:00 PM GMT
Release Date Price: $15.64 (+6.83%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

NRIX.OQ - Nurix Therapeutics Inc
Nurix Therapeutics Inc to Host Investor Update Call
Jun 08, 2026 / 12:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Welcome to the NearX Therapeutics: Unlocking the Full Potential of Beckstead Call. At this time, all participants are to listen-only mode. Later we will conduct a question-and-answer session. I would now like to turn the conference over to our host, Arthur Sands, President and CEO. Arthur, you may begin.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you very much, and good day, everyone.

I'd like to welcome everyone to our call today for a discussion around a very important new collaboration between Neurix and Roche centered on the development and
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot